USFDA completes GMP inspection of Dr Reddy’s Hyderabad API manufacturing facility
Express Pharma
JUNE 17, 2023
The inspection closed with zero observations The United States Food & Drug Administration (USFDA) has completed a GMP inspection at Dr Reddy’s API manufacturing facility in Bollaram, Hyderabad (CTO-3). The inspection was conducted from June 12, 2023 to June 16, 2023. The inspection closed with zero observations. Additionally, the inspection conducted by the USFDA at company’s formulations manufacturing facility in Srikakulam (FTO SEZ PU2), the company has received the Establishme
Let's personalize your content